Incorporating medications and supplements as appropriate to help support your goals
Two separate double-blind, placebo-controlled randomized trials from Imperial College London published in JAMA Network Open in 2022 (women) and 2023 (men) found that kisspeptin significantly changed brain activity in key sexual processing regions in people with hypoactive sexual desire disorder (HSDD)
Researchers utilize this peptide to explore how receptor binding influences pigmentation models, cellular response mechanisms, and downstream signaling cascades
Absorption pilot study points to exciting efficacy results Conducted at Western University of Health Sciences, the placebo-controlled study was led by one of the worlds leading glutathione researchers, Vishwanath Venketaraman, PhD
Some treatments, like laser therapy and microneedling, may cause mild discomfort